HIV

Doctors and Patients Tell Medicare to Approve Facial Reconstruction

To see all comments provided by doctors and patients to Medicare to covince them to pay for facial wasting reconstruction, cut and paste this link to your browser: https://www.cms.hhs.gov/mcd/ncpc_viewpubliccomments.asp?id=20&expand=Y I surely hope that Medicare approves Sculptra, Radiesse and Silikon 1000 reimbursement to help those on disability and to set a precedent for insurance companies to […]

Doctors and Patients Tell Medicare to Approve Facial Reconstruction Read More »

Medicare seeks comments from community and clinicians about facial lipoatrophy reimbursement needs

For everyone who has complained about the lack of insurancereimbursement for facial lipoatrophy treatment, or about the lack ofgood permanent fillers approved for facial lipoatrophy, now is yourchance to do something. Please follow the link belowto submit a comment in response to Mediare’s request for comments onReconstructive Treatment for Facial Lipodystrophy Syndrome. Even ifyou have

Medicare seeks comments from community and clinicians about facial lipoatrophy reimbursement needs Read More »

Comparative Analysis of HIV+ and HIV- Interaction with Testosterone on Bone Mineral Density

Thanks to Jules Levin for providing this paper Comparative Analysis of HIV+ and HIV- Interaction with Testosterone on Bone Mineral Density Reported by Jules Levin ICAAC/IDSA Oct 28 2008 Wash DC R.RAGHUNATHAN 1,2,J.SINACORE 2,K.RYCHLIK 2, J.FARANO 1,C.PACHUCKI 1,2,and N.AZAD 1,2 1 Edward Hines VA Hospital Hines, VA 60141 2 Loyola University Health System,Maywood, IL 60153

Comparative Analysis of HIV+ and HIV- Interaction with Testosterone on Bone Mineral Density Read More »

Tenofovir Dosing for patients with kidney dysfunction

I have seen some confusion about Tenofovir (Viread, which is in Truvada and Atripla) dosing in those with kidney problems in my pozhealth at yahoogroups.com list, so I am posting this information. So far, most of the problems with tenofovir and kidney function have been reported in treatment experienced patients on boosted protease inhibitors, african

Tenofovir Dosing for patients with kidney dysfunction Read More »

The Coming Crisis in HIV Drug Development

Excellent article by Paul Dalton Project Inform The Coming Crisis in HIV Drug DevelopmentBy Paul Dalton June 16, 2008 The last few years have seen tremendous progress in treating people with advanced and drug-resistant HIV. Four powerful drugs became available that either overcame drug resistance (Prezista [darunavir, TMC-114], Intelence [etravirine, TMC-125]) or were from entirely

The Coming Crisis in HIV Drug Development Read More »

Mortality Down 94% in HIV Among Diagnosed

NATAP https://natap.org/_______________________________________________ Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General PopulationKrishnan Bhaskaran, MSc; Osamah Hamouda, MD; Mette Sannes, MLabTech;Faroudy Boufassa, MD; Anne M. Johnson, MD; Paul C. Lambert, PhD; Kholoud Porter, PhD; for the CASCADE Collaboration JAMA. July 2, 2008;300(1):51-59. “…..To our knowledge, no study to date has

Mortality Down 94% in HIV Among Diagnosed Read More »

IMPORTANT INFORMATION ABOUT NANDROLONE IN THE US

QUESTION FROM SOMEONE IN MY POZHEALTH AT YAHOOGROUPS.COM LIST: “I interpret this that once the current supply of the components tomake nandrolone are depleted, there will be no more access tonandrolone here in the US. Am I right or just the number ofcompounding pharmacies may continue to dwindle due to DEA pressures?Thanks everyone,Tom A” MY

IMPORTANT INFORMATION ABOUT NANDROLONE IN THE US Read More »